Keeping You Updated
PharmaTelevision turns the media spotlight upon BIO-Europe
OXFORD, England, October 14 /PRNewswire/ -- PharmaTelevision®, the authoritative channel for the pharmaceutical, biotechnology and related industries, today announced that it is teaming up with the EBD Group to offer delegates at BIO-Europe a Television Interview and Media Training.
Dr Fintan Walton, CEO of PharmaVentures - the company behind PharmaTelevision – said, “Standing out and attaining share of voice is becoming increasingly difficult in the crowded world of biopharma partnering. Effective communication that makes an impact is critical for attracting partners and winning deals. That is why we have devised this unique package for BIO-Europe delegates.”
Dr Walton continues,” By offering media training, we are helping to make our interviewees excellent communicators through the medium of television.”
To find out more about BIO-Europe 2009: Television Interview and Media Training Opportunity from PharmaTelevision, please visit our website.
About PharmaTelevision®
PharmaTelevision is the groundbreaking online TV channel for the biopharma industry, offering daily television news, analysis and feature interviews with industry leaders. Since May 2006, it has rapidly grown and the channel now boasts a global audience of 10,000+ viewers including top industry executives.
PharmaTelevision is produced by professional television industry experts using professional studios worldwide as well as its own studios in Oxford, England. PharmaTelevision produces Open Access Content as well as subscription based Premium Content.
Open Access Content includes the Regional Report – a programme that focuses on the key locations for pharmaceutical and biotech investment, the Financial Report – a programme focused on companies and their performance and the Business Network – a series of interviews and profiles of some of the leading companies in biotech.
Premium Content includes PharmaTelevision News – a daily news and analysis programme, PharmaTelevision News Review – a programme featuring interviews, panel discussions and analysis with leading experts and leaders in our industry and the Business Report – a programme that analyses key business and market trends in our industry.
- ends -
Note to Editors
PharmaVentures Limited (http://www.pharmaventures.com) is a leading international corporate advisory firm supporting its clients' growth ambitions in the health care industry. It has considerable experience and expertise in the field of tangible and intangible transactions, providing advice at both a strategic level, as well as acting as advisor and broker at an implementation level. Its transactional experience includes licensing, joint ventures, mergers, acquisitions and divestments. Its clients are worldwide, including Europe, the USA and AsiaPacific. Clients range from start-ups to global pharmaceutical corporations, diversified industrial corporations, investment houses and government bodies. Its subsidiary PharmaTelevision produces the highly popular PharmaDeals® range of intelligence products including analysis tools and reports as well as the world's first dedicated online pharmaceutical television channel PharmaTelevision® (http://www.pharmatelevision.com).
Now in its 18th year, PharmaVentures is based in Oxford, UK, and employs over 30 people.